Clinical Trials Logo

Filter by:
NCT ID: NCT03170622 Completed - Clinical trials for Inflammatory Bowel Diseases

Evaluation of Faecal Volatile Organic Compounds in the Diagnosis of Paediatric Inflammatory Bowel Disease

VOCs
Start date: October 2, 2017
Phase:
Study type: Observational

Please see description below

NCT ID: NCT03170271 Completed - Asthma Clinical Trials

A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.

ANDHI
Start date: July 7, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the effect of benralizumab on the rate of asthma exacerbations, patient reported quality of life and lung function during the 24-week treatment in patients with uncontrolled, severe asthma with an eosinophilic phenotype. A subset of patients will be assessed for their ongoing chronic rhinosinusitis with nasal polyps. The study design has been updated to include a 56-week open label ANDHI in Practice (ANDHI IP) sub study upon the completion of the 24-week double-blind period of the ANDHI study.

NCT ID: NCT03169179 Completed - Physical Activity Clinical Trials

Physical Activity Wearables in the Police Force: The PAW-Force Trial

Start date: April 19, 2017
Phase: N/A
Study type: Interventional

Policing is an increasingly sedentary occupation and high levels of physical and psychological morbidities are reported by officers and staff. Wearable fitness technology may be a feasible intervention to promote physical activity and improve health. This study aims to assess the feasibility and acceptability of introducing wearable fitness technology (Fitbit™ activity monitors linked to the 'Bupa Boost' smartphone app) as a motivator for increasing physical activity within the police force. Additional aims are to and to assess the potential impact of the intervention on physical activity, sedentary time, health and wellbeing, stress, sickness absence and self-perceived productivity, and to explore which motivational strategies (e.g. individual goal-setting vs. social competitions) are most acceptable and potentially effective and for which groups of staff. A single-group, before and after, mixed methods exploratory trial will be conducted. Approximately 180 police officers and staff from two sites (Plymouth Basic Command Unit and North Dorset) will be recruited to take part. Participants will use the technology for 12 weeks initially followed by a further five months of optional use. A combination of questionnaire surveys, interviews and analysis of staff absence records will be used. Data will be collected pre-intervention, mid-intervention (6 weeks), post-intervention (12 weeks) and follow-up (8 months). Primary outcomes are change in objectively recorded step count, self-reported physical activity and sedentary time. Secondary outcomes include general health and wellbeing, perceived stress and productivity, sickness absence, engagement with the intervention and perceived usability and usefulness. This study will add to our understanding of the feasibility and acceptability of mobile fitness technology in a specific workplace setting, and inform a potential larger trial within the police force.

NCT ID: NCT03169153 Completed - Refractive Error Clinical Trials

Clinical Comparison of Silicone Hydrogel Monthly Lenses

Start date: September 22, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare AIR OPTIX® plus HydraGlyde (AOHG) contact lenses to ACUVUE® VITA® (VITA) contact lenses for total lipid uptake (total of surface and bulk uptake) after 30 days of wear by high lipid depositors.

NCT ID: NCT03168984 Completed - Clinical trials for Healthy Japanese and Caucasian Subjects

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects

Start date: May 5, 2017
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the pharmacokinetics, safety and tolerability of UCB0942 in Japanese and Caucasian subjects.

NCT ID: NCT03168503 Completed - Healthy Clinical Trials

Synbiotic Approach to Immunity and Metabolism in the Elderly Study

SAIMES
Start date: December 2013
Phase: N/A
Study type: Interventional

The aging process leads to a marked decline in immune function (immunosenescence), causing a significant reduction in immune response after vaccination or infections. Dietary intervention is an attractive, safe and non-invasive way to impact on gut bacteria and subsequently the functioning of the immune system. The ability of the dietary supplementation to alter these functions can be of particular importance in those groups that have an underdeveloped, poorly functioning immune system such as infants, immuno-compromised subjects or elderly. Research over the past two decades has provided evidence that administration of probiotics (live microorganisms which, when administered in adequate amounts, confer a health benefit on the host) could enhance immune function. Lactobacilli and bifidobacteria are the most common probiotics used in humans and various strains have been shown to have immunostimulatory properties in vitro and in experimental models, these properties include modulation of cytokine production. evidence exists of the immunostimulating effects of certain probiotics and the potential to use prebiotics to increase the levels of beneficial bacteria (which are known to be reduced in elderly population). Furthermore, by providing a probiotic at the same time as a prebiotic conditions for survival are enhanced. To date, only a small number of studies conducted have been randomised and/or placebo controlled to unequivocally demonstrate efficacies.

NCT ID: NCT03168399 Completed - Phenylketonuria Clinical Trials

Evaluation of PKU Explore

PKU Explore
Start date: June 8, 2017
Phase: N/A
Study type: Interventional

To evaluate the acceptability, tolerance and effect on metabolic control of PKU Explore, a renovated Phe free protein substitute for the dietary management of PKU in children from 6 months to 5 years.

NCT ID: NCT03168243 Completed - Nutrition Clinical Trials

High Energy High Protein Tube Feed Study

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Enteral tube feeds are commonly used to meet the entire or partial nutritional requirements of patients with disease-related malnutrition and other conditions who need nutrition support. A large proportion of tube fed patients have increased protein and/or energy requirements due to a higher body mass or increased metabolic stress as a result of disease, surgery or trauma. A high energy, high protein feed has been developed to help meet the needs of such patients. The aim of this study is to investigate the tolerance, compliance and acceptability of this high energy high protein tube feed in adult patients who require nutritional support via tube feeding. 50 eligible patients requiring tube feeding will receive the high energy, high protein feed, according to nutritional requirements for 4 weeks. The primary outcome is nutritional intake, and secondary outcomes include gastrointestinal (GI) tolerance, compliance, acceptability and functional measures. Additional exploratory outcomes of quality of life and micronutrient levels will also be investigated.

NCT ID: NCT03167762 Completed - Clinical trials for Basal Cell Carcinoma

Photographing the Skin During Photodynamic Therapy

Start date: June 22, 2017
Phase: N/A
Study type: Interventional

Photodynamic therapy (PDT) is used to treat some types of sun-damaged skin and low-grade forms of growths. A cream is applied to the skin, and the chemical in this cream is absorbed in to the skin and converted in to a 'photosensitiser'. This photosensitiser is fluorescent, meaning that it produces red light when blue light is shone on it. By measuring how much light is given off with a camera, the investigators can determine how much photosensitiser is present in the skin. Also, it is thought that more of the chemical is converted to the active photosensitiser if the skin is warmer, so the investigators plan to measure the temperature of the skin using a thermal camera. Light is shone on to the skin and this activates the photosensitiser, treating the problem area and leaving healthy skin intact. This research will increase the investigators understanding of how PDT works, and may help the investigators to improve treatment regimens so that they can be made more effective and better tolerated

NCT ID: NCT03167697 Completed - Phenylketonurias Clinical Trials

Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

This study centres around a new one-a-day phenylalanine-free protein substitute for phenylketonuria patients. Fifty eligible adults (≥ 16 years) with proven phenylketonuria or hyperphenylalaninemia will be recruited and randomly allocated to one of two intervention arms (n = 25 per arm). Following a 3-day baseline period, and in addition to routine nutritional management, patients will receive either one sachet of the new protein substitute daily (intervention) or continue their usual dietary and/or protein substitute regimen (maximum of 1 protein substitute per day (equal to 20g protein equivalent) control) for 28 days.